ConductScience.org, home

Paper9815840

Optimal sampling strategies for bayesian estimation of docetaxel (Taxotere) clearance.

Baille P and 6 others. Clin Cancer Res, 1997. Cited by 47 papers, by iCite.

Cite this record

ConductScience Library. Optimal sampling strategies for bayesian estimation of docetaxel (Taxotere) clearance. Papers, record 9815840. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9815840

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Optimal sampling strategies for bayesian estimation of docetaxel (Taxotere) clearance.
PubMed
Journal
Clin Cancer Res
PubMed
Year
1997
PubMed
Publication types
Clinical Trial, Clinical Trial, Phase I, Comparative Study, Journal Article
PubMed
Citations, by iCite
47
iCite
Relative citation ratio, by iCite
1.6
iCite
Revised in PubMed
2018-12-01
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Baille PP
2Bruno RR
3Schellens JHJ H
4Webster LKL K
5Millward MM
6Verweij JJ
7Montay GG

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Agents, PhytogenicMajor topic
Bayes TheoremMajor topic
PaclitaxelMajor topic
Sampling StudiesMajor topic
TaxoidsMajor topic
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Non-Small-Cell Lung
Cisplatin
Docetaxel
Humans
Infusions, Intravenous
Likelihood Functions
Lung Neoplasms
Metabolic Clearance Rate
Neoplasms
Prospective Studies
Specimen Handling

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.

PMIDTitleJournalYearIn PapersSource
38734836Using maximum plasma concentration (Cmax) to personalize taxane treatment and reduce toxicity.Cancer Chemother Pharmacol2024https://conductscience.org/library/papers/38734836PubMed
32309383Clinical pharmacokinetics and drug exposure-toxicity correlation study of docetaxel based chemotherapy in Chinese head and neck cancer patients.Ann Transl Med2020https://conductscience.org/library/papers/32309383PubMed
21692829Effect of grapefruit juice on the pharmacokinetics of docetaxel in cancer patients: a case report.Br J Clin Pharmacol2011https://conductscience.org/library/papers/21692829PubMed
20628376Effect of ABCB1 C3435T polymorphism on docetaxel pharmacokinetics according to menopausal status in breast cancer patients.Br J Cancer2010https://conductscience.org/library/papers/20628376PubMed
18611060Population pharmacokinetics and pharmacodynamics for treatment optimization in clinical oncology.Clin Pharmacokinet2008https://conductscience.org/library/papers/18611060PubMed
17595656Clinical pharmacodynamic factors in docetaxel toxicity.Br J Cancer2007https://conductscience.org/library/papers/17595656PubMed
17518507A systematic review of limited sampling strategies for platinum agents used in cancer chemotherapy.Clin Pharmacokinet2007https://conductscience.org/library/papers/17518507PubMed
14678339Population pharmacokinetics of weekly docetaxel in patients with advanced cancer.Br J Clin Pharmacol2004https://conductscience.org/library/papers/14678339PubMed
12889741Pharmacokinetic-pharmacodynamic guided trial design in oncology.Invest New Drugs2003https://conductscience.org/library/papers/12889741PubMed
12445024Development and validation of limited sampling strategies for prediction of the systemic exposure to the novel anticancer agent E7070 (N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide).Br J Clin Pharmacol2002https://conductscience.org/library/papers/12445024PubMed
11392450Population pharmacokinetics and pharmacokinetic-pharmacodynamic relationships for docetaxel.Invest New Drugs2001https://conductscience.org/library/papers/11392450PubMed
10803455Adaptive control methods for the dose individualisation of anticancer agents.Clin Pharmacokinet2000https://conductscience.org/library/papers/10803455PubMed
10233199A pharmacokinetic model for alpha interferon administered subcutaneously.Br J Clin Pharmacol1999https://conductscience.org/library/papers/10233199PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9815840

GET https://conductscience.org/api/papers/v1/9815840/authors